GenEndeavor
Hayward
About GenEndeavor
GenEndeavor is a biotechnology firm that creates platforms for the next generation of molecular technology to enable quick and accurate identification of infectious and genetic illnesses in real time at the point of presentation. Its objective is to increase access to extremely early genetic and infectious illness screening. They aim to identify diseases while they are still curable by lowering the detection limit of uncommon mutations and infections. Its assay technology platforms will make point-of-care testing sensitive, quick, and economical.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $621.0K
- Last round: Grant (Aug 2012)
- Website: genendeavor.com
Industries & Categories
Biotechnology, Health Diagnostics, Medical, Personal Health
Social Profiles
Canonical: https://fsome.com/organization/genendeavor-2824094 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.